Enable job alerts via email!
Boost your interview chances
A leading radiation oncology group in Oregon seeks a new associate to join their award-winning team. The opportunity is open to recent graduates and seasoned candidates alike, emphasizing teamwork in advanced radiation modalities, including proton therapy and brachytherapy. This salaried position offers long-term prospects in a double-accredited department with cutting-edge technology and a supportive environment.
Our private and very busy group of four academically-minded community radiation oncologists is looking for a new associate.
Our group has been a national leader in Protons, SBRT, HDR brachytherapy, Medical Physics, and in other areas including a Nuclear Oncology expansion of Theranostics.
A traditional work ethic and the ability to flourish in a team setting are key attributes needed. Interviews will be available online or during ASTRO.
Recent or new graduates looking for clinical experience in advanced modalities or a seasoned candidate with experience in contemporary therapy are encouraged to apply.
This is a salaried position with a multi-year employment period and the opportunity for a permanent career for the appropriate candidate.
We are a single location, double-accredited department with image-guided compact scanning Proton therapy. We offer photon radiotherapy on three Linacs, including Radixact with Clear Imaging. The department utilizes Raysearch planning software, BrainLab radiosurgery, and surface-guidance imaging.
Our center is recognized for extensive in-department imaging, including MRI Sim, CT Sim, PET/CT, SPECT-CT, and a dedicated compact CT for brachytherapy. Nuclear Oncology with radiopharmaceuticals is also offered by all of our physicians.
We have an award-winning physics and dosimetry team and a successful medical physics residency program with a Theranostics fellowship.
Our group is assisted by 8 RNs, each with a dedicated nurse, and three PAs employed by the group. The practice is expected to expand to six members by 2027.